Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management

…, T Molnár, T Raine, S Sebastian… - Journal of Crohn's …, 2017 - academic.oup.com
11.1. General The treatment strategy for ulcerative colitis [UC] is mainly based on the severity,
distribution [proctitis, left-sided, extensive] 1 and pattern of disease. The latter includes …

Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction

S Sebastian, S Johnston, T Geoghegan… - Official journal of the …, 2004 - journals.lww.com
BACKGROUND: Self-expanding metal stents have been used in the management of colorectal
obstruction as an alternative to emergency surgery. Our aim was to systematically review …

European evidence based consensus for endoscopy in inflammatory bowel disease

…, I Ordás, A Repici, B Rosa, S Sebastian… - Journal of Crohn's …, 2013 - academic.oup.com
Endoscopy plays an essential role in the diagnosis, management, prognosis, and surveillance
of inflammatory bowel disease (IBD), but surprisingly there are few available guidelines. 1…

3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 2: surgical management and special situations

…, S Ardizzone, CJ Buskens, S Sebastian… - Journal of Crohn's …, 2017 - academic.oup.com
This paper is the second in a series of two publications relating to the European Crohn’s
and Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and …

Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines

…, G Morana, D Pendsé, S Sebastian… - Journal of Crohn's …, 2013 - academic.oup.com
The management of patients with IBD requires evaluation with objective tools, both at the time
of diagnosis and throughout the course of the disease, to determine the location, extension…

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

…, CW Lees, AL Hart, M Parkes, S Sebastian… - The lancet …, 2019 - thelancet.com
Background Anti-TNF drugs are effective treatments for the management of Crohn's disease
but treatment failure is common. We aimed to identify clinical and pharmacokinetic factors …

East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort

…, S Almer, Y Zhulina, J Halfvarson, N Arebi, S Sebastian… - Gut, 2014 - gut.bmj.com
Objective The incidence of inflammatory bowel disease (IBD) is increasing in Eastern Europe.
The reasons for these changes remain unknown. The aim of this study was to investigate …

Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD

…, AM Verma, S Jochum, TJ McDonald, S Sebastian… - Gut, 2021 - gut.bmj.com
Objective Delayed second dose SARS-CoV-2 vaccination trades maximal effectiveness for
a lower level of immunity across more of the population. We investigated whether patients …

Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: systematic review and meta-analysis

…, NA Kennedy, AHJ Kim, V Sharma, S Sebastian - Autoimmunity …, 2022 - Elsevier
Objectives The treatment for COVID-19 often utilizes immune-modulating drugs. These
drugs are also used in immune mediated inflammatory diseases (IMIDs). We performed a …

[HTML][HTML] COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case …

…, S Balarajah, F Fiorentino, S Sebastian… - The lancet …, 2022 - thelancet.com
Background The effects that therapies for inflammatory bowel disease (IBD) have on immune
responses to SARS-CoV-2 vaccination are not yet fully known. Therefore, we sought to …